“Partnering with Demeetra strengthens our ability to support biotech companies with a rapid and reliable path to GMP material ...
Sotyktu (deucravacitinib) for treatment of adults with active psoriatic arthritis (PsA). Sotyktu is an oral, selective ...
New Annex 1–compliant filling line expands eye care production in Italy; additional systems planned for U.S. facilities.
NewcelX Ltd., a clinical-stage company, has entered a strategic collaboration with Eledon Pharmaceuticals Inc., a ...
Spruce Biosciences Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for ...
Will expand manufacturing capacity at Lonza’s Houston facility to support growing demand for Genetix’s ZYNTEGLO ...
AstraZeneca and Daiichi Sankyo’s Enhertu received Priority Review in the U.S. from a supplemental Biologics License Application.
Neuland Laboratories Ltd. plans to open a commercial‑scale peptide manufacturing facility in summer 2026 at its 17‑acre Bonthapally campus in Hyderabad.
Kindeva, a global drug delivery CDMO, has appointed Mike Cowhig as Chief Legal Officer to drive legal strategy, enterprise risk management and corporate governance.
New South San Francisco center showcases how cutting-edge cryo-electron microscopy is transforming and accelerating drug ...
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds ...
Designing modular, automated vial fill-finish lines that balance high-output demands with small-batch precision in an Annex 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results